|
Missing Procedures Noted in Utah Company’s Form 483
An FDA inspection of Salt Lake City-based BioMeridian International resulted in 16 observations, most relating to missing procedures or documentation. Quality system procedures and instructions had not been established, and there were no management review procedures or designated management representative, the form states. The company had not performed an internal quality audit since spring 2007.
The GMP Letter |
|
Register Now
Archives